While investors have long treated the pharmaceuticals’ industry with caution, those that avoid the sector are missing out on clear opportunities. While navigating the fast-developing industry is not ...

Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced the initiation of its Phase 2 clinical study to assess the safety and tolerability of crinecerfont in children aged 3 months to under 4 ...

By integrating operational tech stacks and compliance frameworks directly into its portfolio, Cronus Capital aims to ...

IND authorization paves the way for initiation of GT-02287 Phase 2 clinical development in the U.S., expected during 3Q26FDA’s decision follows ...

Samsung Bioepis Co., Ltd. announced today that the Phase 1 and Phase 3 studies on SB27, a proposed biosimilar to Keytruda 1 (pembrolizumab), have met their primary endpoints.

A vacant York City office site is slated for apartments and mixed-use space, backed by a state grant and local leaders.

After an interim peek, an independent data monitoring board has recommended Avecho's cannabinoid based insomnia trial ...

SHELTON, CT / ACCESS Newswire / June 22, 2026 / NanoViricides, Inc. (NYSE Amer.:NNVC) (the "Company") today announced ...

The video presents India’s progress as a modern developing nation with growth across the economy, technology, infrastructure, energy, and innovation. It highlights the country’s expanding startup ...

Left to right: Lola Fashoyin-Aje, Steven Fleischer, Vijay Kumar, Travis Quigley, Rosanna Ricafort, Nirali N. Shah, and Chris White. (Source: FOCR) More flexibility in early-phase development for cell ...

Many product development teams are turning to artificial intelligence (AI) to speed up individual work, automate repetitive tasks, and analyze customer information for insights. But because AI is ...

ROCHESTER — Waterstone Properties has begun to reveal the second and third phases of its massive development, following the December sale of The Ridge Marketplace to Torrington Properties. Rochester ...